IXHL Incannex Healthcare Inc.

NASDAQ
$1.97

Incannex Healthcare Inc. (IXHL) is expected to report earnings on February 11, 2027, after the market close. The consensus earnings estimate is a loss of $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.5% since its last earnings release on November 12, 2026.

Incannex Healthcare Beat Consensus Estimates
Earnings Date
2nd Quarter, Dec 2026
Feb 11
Thursday · After Close
Earnings Whisper
-
vs ($0.66)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.69

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Incannex Healthcare Inc.

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.